Navigation Links
Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent
Date:1/26/2009

ABBOTT PARK, Ill., Jan. 26 /PRNewswire-FirstCall/ -- Data published online today in Circulation from the SPIRIT III U.S. pivotal trial evaluating the XIENCE V(TM) Everolimus Eluting Coronary Stent System demonstrated that Abbott's market-leading XIENCE V outperforms the TAXUS(R) Express2(TM) Paclitaxel-Eluting Coronary Stent System (TAXUS) in reducing major adverse cardiac events (MACE) at two years. In the SPIRIT III trial of 1,002 patients, XIENCE V demonstrated a 45 percent reduction in the risk of MACE, and a 40 percent reduction in the risk of cardiac death or heart attack (myocardial infarction, or MI) at two years in patients treated with XIENCE V compared to those treated with TAXUS. Additionally, at two years the study demonstrated a 32 percent reduction in the risk of target vessel failure (TVF, cardiac events related to the treated vessel) for XIENCE V compared to TAXUS. These published results were first presented in May 2008 at the EuroPCR Congress in Barcelona.

"As published in Circulation, the SPIRIT III study results demonstrate that the clinical benefits of XIENCE V continue to improve between one and two years of follow-up after stent implantation compared to TAXUS," said Gregg W. Stone, M.D., Columbia University Medical Center; chairman, Cardiovascular Research Foundation, New York; and principal investigator of the SPIRIT III trial. "These data reinforce our earlier findings demonstrating the excellent angiographic and clinical results with the XIENCE V stent, resulting in fewer heart attacks and repeat reinterventions."

The SPIRIT III trial demonstrated the following key results for XIENCE V at two years:

-- A 45 percent reduction in the risk of MACE compared to TAXUS (7.3 percent for XIENCE V vs. 12.8 percent for TAXUS, p-value=0.004)*. MACE is an important composite clinical measure of safety and effic
'/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm
2. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
3. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
4. The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
5. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
6. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
7. Franklin & Seidelmann Publishes Complex Podiatry MRI Study
8. ImQuest Publishes Results of Important Structure Activity Relationship Program on Dual Acting Pyrimidinediones
9. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
10. Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology
11. New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... , June 30, 2015  Ardelyx, Inc. (NASDAQ: ... cardio-renal, gastrointestinal and metabolic diseases, today announced that the ... 14, 2015, from 8:00 a.m.- 1:00 pm EDT in ... The Ardelyx senior management team will present an ... compound, tenapanor, which has completed Phase 2b clinical trials ...
(Date:6/30/2015)... JERUSALEM , June 30, 2015 ... http://www.oramed.com ), a clinical-stage pharmaceutical Company focused on the ... the first patient has been screened in the Company,s ...  This U.S. based study will be performed under the ... the U.S. Food and Drug Administration (FDA). ...
(Date:6/30/2015)... 2015 /PRNewswire/ – Small Cap IR issues report. Recently, ... custom Arrayit blood card technology to Vivos, Global Genome ... Vivos offers an impervious, impenetrable and permanent DNA storage ... child on Earth, a safe and secure nuclear blast-proof, ... allow the rapid collection, separation, drying and storage of ...
Breaking Medicine Technology:Ardelyx to Host Inaugural R&D Investor Day in New York City on July 14, 2015 2Oramed Enrolls First Patient in its Phase IIb Oral Insulin Study 2Oramed Enrolls First Patient in its Phase IIb Oral Insulin Study 3Small Cap IR - Empowering the Age of Genetic Enlightenment 2
(Date:6/30/2015)... ... June 30, 2015 , ... ADVOCATE, the ... have been awarded the exclusive billing agreements with Jackson Radiology Associates in Jackson, ... encompassing their proprietary suite of billing process software functionality called Experience Based Technology ...
(Date:6/30/2015)... ... ... On June 26, 2015, Harper’s Bazaar Magazine in an article titled “5 ... not expect to cause acne flare-ups. The list includes pillowcases, cell phones, ... are clogged pores and bacteria and each of the named triggers unexpectedly creates a ...
(Date:6/30/2015)... ... June 30, 2015 , ... Lakeview ... more than doubled the size of its medical staff to further enhance its ... which includes physicians, nurse practitioners and physician assistants -- now totals 17, compared ...
(Date:6/30/2015)... ... 2015 , ... Family and professional dementia caregivers are invited ... 9, 2015 at the Hyatt Regency Denver Tech Center from 7:30 am-4:30 pm. ... Campbell, the wife and daughter of singer Glen Campbell, who will discuss their ...
(Date:6/30/2015)... ... June 30, 2015 , ... From the moment a patient enters the office ... care that they receive and the luxury in which they are bathed. The ... proud to offer the same experience, just better! , Their office is a state-of ...
Breaking Medicine News(10 mins):Health News:ADVOCATE Wins Billing Agreements with Jackson Radiology Associates 2Health News:A List of 5 Surprising Acne Triggers and the Latest Acne Treatment Options 2Health News:Lakeview Health, a Nationally Recognized Drug Rehabilitation Center in Florida, Doubles Size of Medical Staff 2Health News:Family of Singer Glen Campbell to Discuss Living with Dementia at the Alzheimer's Association of Colorado's 26th Annual Education Symposium 2Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 2Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 3Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 4
... Association of Urology (EAU) and Europa Uomo, the ... have entered into an,affiliated partnership as part of ... in Europe with regards to urological diseases. Professor ... this unique,EAU affiliated partnership, Europa Uomo will gain ...
... helpings of gravy and dessert at the holiday table are ... thought. According to a new research report recently appearing online ... diet that is high in fat and in sugar actually ... too much fat. This means these foods hit you with ...
... , SHENZHEN, China, Nov. 30 ... operating subsidiary Mellow Hope finalized contract details with one of ... promises additional increase in revenues for Hard to Treat Diseases ... the Indian company secures the supply of raw pharmaceutical material ...
... , MINNEAPOLIS, Nov. 30 A new study has found ... a current intention to shop for and possibly switch their Medicare ... Over the past four years, the "intention to switch" measure has ... not everyone with some intention to switch actually will leave their ...
... bills stack up , MONDAY, Nov. 30 (HealthDay News) -- ... differ in a number of ways but achieve the same ... , Legislation approved by the House of Representatives earlier this ... Senate is preparing to debate a proposal to expand coverage ...
... ... Institute of Women,s Health of North America in Florida will offer 2009 H1N1 influenza vaccination. ... visit our website to locate a convenient LOCATION near you or call 1-877-966-3672. ... (Vocus) November 30, 2009 ...
Cached Medicine News:Health News:Western diets turn on fat genes 2Health News:Hard to Treat Diseases (HTDS) Closes 1 Million Dollar Contract Indian Pharmaceutical 2Health News:Hard to Treat Diseases (HTDS) Closes 1 Million Dollar Contract Indian Pharmaceutical 3Health News:More Seniors Considering Health Insurance Switch 2Health News:Health Reform: What's in It for You? 2Health News:Health Reform: What's in It for You? 3Health News:2009 H1N1 Influenza Vaccination Being Offered at Various Affiliated Campuses of the Institute of Women's Health of North America in Florida 2Health News:2009 H1N1 Influenza Vaccination Being Offered at Various Affiliated Campuses of the Institute of Women's Health of North America in Florida 3
The adult blanket provides full coverage for patients of all sizes. The generous size and versatility of these blankets include extra material for the shoulders and feet. The foot drape also reduces ...
This revolutionary system combines the CSZ Head Wrap and Patient Vest for a non-invasive whole body hypothermia system. This method of cooling the patient allows for early treatment that is fast, cos...
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
The Bair Hugger outpatient blanket makes it easy to give your patients the benefit of prewarming and enhance patient comfort during outpatient procedures....
Medicine Products: